We provide you with 20 years of free, institutional-grade data for VCNX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VCNX. Explore the full financial landscape of VCNX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| FRIEDBERG ALBERT | Open Market Purchase | 1,818 | $4.95 | 2024-05-31 | |
| FRIEDBERG ALBERT | Grant, award...etc | 102,960 | $7.77 | 2024-04-01 | |
| Zauderer Maurice | Grant, award...etc | 38,610 | $7.77 | 2024-04-01 | |
| Zauderer Maurice | Grant, award...etc | 413,793 | $0.72 | 2024-02-09 | |
| FRIEDBERG ALBERT | Grant, award...etc | 1,655,172 | $0.72 | 2024-02-09 | |
| Van Strydonck, Gerald E. | Sale | -3,149 | $0.72 | $2,267 | 2023-12-28 |
| Van Strydonck, Gerald E. | Sale | -1,334 | $0.67 | $894 | 2023-12-12 |
| Zauderer Maurice | Grant, award...etc | 2,051,282 | $0.16 | 2023-09-25 | |
| FRIEDBERG ALBERT | Grant, award...etc | 6,711,552 | $0.37 | 2023-05-16 | |
| Zauderer Maurice | Grant, award...etc | 731,707 | $0.41 | 2023-04-03 | |
| FRIEDBERG ALBERT | Grant, award...etc | 4,146,341 | $0.41 | 2023-04-03 | |
| Frieberg Jacob B. | Grant, award...etc | 188,928 | $0.53 | 2022-11-28 | |
| Zauderer Maurice | Grant, award...etc | 1,511,430 | $0.53 | 2022-11-28 | |
| Zauderer Maurice | Open Market Purchase | 1,801,801 | $1.11 | 2022-01-31 | |
| FRIEDBERG ALBERT | Open Market Purchase | 1,801,801 | $1.11 | 2022-01-31 | |
| FRIEDBERG ALBERT | Open Market Purchase | 1,801,801 | $1.11 | 2022-01-31 | |
| Frieberg Jacob B. | Open Market Purchase | 90,090 | $1.11 | 2022-01-31 | |
| Evans Elizabeth E. | Initial | 2021-05-21 | |||
| Leonard John E. | Derivatives Exercise | 1,000 | 2020-09-03 | ||
| FRIEDBERG ALBERT | Open Market Purchase | 1,126,760 | $3.55 | 2020-07-10 | |
| FRIEDBERG ALBERT | Open Market Purchase | 9,000 | $4.18 | 2020-03-30 | |
| FRIEDBERG ALBERT | Open Market Purchase | 3,000 | $4.4 | 2020-03-26 | |
| FRIEDBERG ALBERT | Open Market Purchase | 7,040 | $4.28 | 2020-03-17 | |
| FRIEDBERG ALBERT | Open Market Purchase | 982,318 | $5.09 | 2020-01-27 | |
| Zauderer Maurice | Open Market Purchase | 98,231 | $5.09 | 2020-01-27 | |
| Frieberg Jacob B. | Open Market Purchase | 39,292 | $5.09 | 2020-01-27 | |
| FRIEDBERG ALBERT | Open Market Purchase | 1,838,235 | $4.08 | 2019-07-31 | |
| Zauderer Maurice | Open Market Purchase | 183,824 | $4.08 | 2019-07-31 | |
| FRIEDBERG ALBERT | Open Market Purchase | 1,052 | $3.99 | 2019-07-29 |
The information provided in this report about VCNX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Vaccinex, Inc(NASDAQ:VCNX) 
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune diso...
Website: http://www.vaccinex.com
Founded: 2001
Full Time Employees: 45
Sector: Healthcare
Industry: Biotechnology